Thorsten A. Kirschberg

9 Patents

• US126177832026

  Heterocyclic GLP-1R Agonists

  BIOMEA FUSION, Inc.

  0 cites
• US125287912026

  Thyroid Hormone Receptor Beta Agonist Compounds

  Terns Pharmaceuticals, Inc.

  0 cites
• US124545242025

  (r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1h-benzo[d]imidazole-5-carboxamide, or a Pharmaceutically Acceptable Salt or Tautomer Thereof, for Treating Certain Leukemias

  Terns Pharmaceuticals, Inc.

  0 cites
• US123981272025

  Thyroid Hormone Receptor Beta Agonist Compounds

  Terns Pharmaceuticals, Inc.

  0 cites
• US122408352025

  Substituted Benzamides as Intermediates in the Synthesis of Inhibitors of Tyrosine Kinase Enzymatic Activity

  Terns Pharmaceuticals, Inc.

  0 cites
• US122151132025

  Crystalline Forms of N[4[4-(4-morpholinyl)-7h-pyrrolo[2-3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-protein-1-yl)amino]-1-piperidinyl]methyl]2-pyridinecarboxamide]

  Biomea Fusion, Inc.

  0 cites
• US121616252024

  Substituted Pyrrolizine Compounds and Uses Thereof

  Gilead Sciences, Inc.

  0 cites
• US119457852024

  Pyrazine Compounds as Inhibitors of FLT3

  Biomea Fusion, Inc.

  0 cites
• US119052992024

  Cot Modulators and Methods of Use Thereof

  Gilead Sciences, Inc.

  0 cites